BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4242953)

  • 1. Pharmacological activities of a new antitussive agent: morphethylbutyne (2-phenoxy-isobutyric acid, 2-morpholine-ethyl ester).
    Marchetti E; Samueli F; Stucchi F
    Arch Int Pharmacodyn Ther; 1969 Apr; 178(2):400-6. PubMed ID: 4242953
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of ethyl dibunate, a new antitussive agent.
    Shemano I; Beiler JM; Hitchens JT
    Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):410-24. PubMed ID: 6031473
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative pharmacological study of antitussive preparations derived from piperazine].
    Le Douarec JC; Régnier G; Canévari R
    Arzneimittelforschung; 1965 Nov; 15(11):1330-7. PubMed ID: 5899868
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological studies on a substance with antitussive and respiration stimulating properties].
    Püschmann S; Engelhorn R
    Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:296-3. PubMed ID: 4145312
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological properties of xyloxemine hydrochloride, 2-[2-(di-2,6-xylylmethoxy) ethoxy]-N,N-dimethylethylamine hydrochloride (BS 6748), a new antitussive agent.
    Tersteege HM; Funcke AB; Louwerse WJ; Nauta WT
    Arch Int Pharmacodyn Ther; 1966 Jun; 161(2):314-33. PubMed ID: 5926874
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological studies on a new specifically potent antitussive agent, 14-hydroxydihydro-6 beta-thebainol-4-methylether (oxymethebanol).
    Kobayashi S; Hasegawa K; Mori M; Takagi H
    Arzneimittelforschung; 1970 Jan; 20(1):43-6. PubMed ID: 5467447
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution and metabolic fate of morphethylbutyne in rats (2-phenoxy-isobutyric acid, 2-morpholine-ethyl ester).
    Marchetti E; Bergesi G
    Arch Int Pharmacodyn Ther; 1970 Apr; 184(2):245-51. PubMed ID: 5453229
    [No Abstract]   [Full Text] [Related]  

  • 8. Some observations on the pharmacology of mitragynine.
    Macko E; Weisbach JA; Douglas B
    Arch Int Pharmacodyn Ther; 1972; 198(1):145-61. PubMed ID: 4626477
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of antitussive drugs in the central part of the cough reflex tract].
    Hahn KJ; Friebel H
    Med Pharmacol Exp Int J Exp Med; 1966; 14(1):87-97. PubMed ID: 5952131
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological properties of noscapine].
    Sukhinina GP
    Farmakol Toksikol; 1968; 31(6):702-5. PubMed ID: 4388890
    [No Abstract]   [Full Text] [Related]  

  • 11. The general pharmacology of a novel antitussive compound RU 20201.
    Pickering RW; James GW
    Arzneimittelforschung; 1979; 29(4):642-6. PubMed ID: 314807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological studies of a new potent antitussive agent, 14-hydroxy-dihydro-6 beta-thebainol-4-methyl ether (oxymethebanol)].
    Takagi H; Kobayashi S; Kumakura S; Mori M; Koike H
    Nihon Yakurigaku Zasshi; 1969 Mar; 65(2):120-45. PubMed ID: 4390383
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of a new antitussive and respiration-stimulating agent on the respiratory E -neurons in the medulla oblongata of the cat].
    Engelhorn R; Trieb G; Weller E
    Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:305-1. PubMed ID: 4740106
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between the antitussic and analgesic activity of substances.
    Nosál'ová G; Strapková A; Korpás J
    Acta Physiol Hung; 1991; 77(2):173-8. PubMed ID: 1927541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitussive action of the new anilide derivative vadocaine hydrochloride compared with codeine phosphate in four animal models.
    Männistö PT; Karttunen P; Lahovaara S; Nissinen E; Davies JE; Algate DR; Baines MW
    Arzneimittelforschung; 1988 Apr; 38(4A):598-604. PubMed ID: 3395394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacologic studies on the new antitussive agent, 3-(2,2-diphenylethyl)-5-(2-piperidinoethyl)-1,2,4-oxadiazole].
    Tardos L; Erdély I
    Arzneimittelforschung; 1966 May; 16(5):617-21. PubMed ID: 6014427
    [No Abstract]   [Full Text] [Related]  

  • 17. Antitussive potencies of l- and d-opiates and their inhibition of codeine binding.
    Chau TT; Harris LS
    NIDA Res Monogr; 1984 Mar; 49():77-84. PubMed ID: 6090920
    [No Abstract]   [Full Text] [Related]  

  • 18. [Difference in the effects of antitussive drugs on respiration and cough reflex].
    Yanaura S; Kitagawa H; Hosokawa T; Misawa M
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):213-22. PubMed ID: 6229455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitussive activity and other related pharmacological properties of 2-allyoxy-4-chloro-N-(2-diethylaminoethyl) benzamide.
    Kasé Y; Kawasaki A; Miyata T; Tsumagari T; Yuizono T
    Jpn J Pharmacol; 1966 Dec; 16(4):342-52. PubMed ID: 5298923
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacology of N-(2-picolyl)-N-phenyl-N-(2-piperidinoethyl)amine (TAT-3), a new antitussive agent.
    Kasé Y; Yuizono T; Tachibana K; Miyata T; Kito G; Miyano S
    Arzneimittelforschung; 1969 Dec; 19(12):1916-27. PubMed ID: 4392320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.